August 25, 2009
by Arvin Moser, Team Manager, Application Scientists, ACD/Labs
In past blogs, I have ascribed the process of peak matching as an integral part of structure elucidation. In this series, peak matching is demonstrated with the use of MS data.
The scheme below shows a parent compound (2-oxo-N,2-diphenylacetamide) with two possible sites for hydrogenation. The potential modified compounds are 2-hydroxy-N,2-diphenylacetamide and 2-hydroxy-1-phenyl-2-(phenylamino)ethanone labeled A and B, respectively.
The ESI+ full scan MS below belong to the parent compound (top) and the modified compound (bottom). With the given data, can the suspected site of modification be determined?
